TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK

Rosen Law Firm is investigating potential securities claims for Cytokinetics investors who purchased stock between December 27, 2023 and May 6, 2025, alleging false statements about drug approval timeline and regulatory risks.

Insights
CYTK   negative

Lawsuit alleges company made misleading statements about drug approval timeline and failed to disclose material regulatory risks, potentially causing investor damages